These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11291075)

  • 1. Up-regulation of MUC1 in mammary tumors generated in a double-transgenic mouse expressing human MUC1 cDNA, under the control of 1.4-kb 5' MUC1 promoter sequence and the middle T oncogene, expressed from the MMTV promoter.
    Graham RA; Morris JR; Cohen EP; Taylor-Papadimitriou J
    Int J Cancer; 2001 May; 92(3):382-7. PubMed ID: 11291075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation.
    Schroeder JA; Masri AA; Adriance MC; Tessier JC; Kotlarczyk KL; Thompson MC; Gendler SJ
    Oncogene; 2004 Jul; 23(34):5739-47. PubMed ID: 15221004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.
    Hu C; Diévart A; Lupien M; Calvo E; Tremblay G; Jolicoeur P
    Am J Pathol; 2006 Mar; 168(3):973-90. PubMed ID: 16507912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice.
    Tomioka Y; Morimatsu M; Nishijima K; Usui T; Yamamoto S; Suyama H; Ozaki K; Ito T; Ono E
    Biochem Biophys Res Commun; 2014 Jul; 450(1):532-7. PubMed ID: 24924635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice.
    Peat N; Gendler SJ; Lalani N; Duhig T; Taylor-Papadimitriou J
    Cancer Res; 1992 Apr; 52(7):1954-60. PubMed ID: 1372533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM; Leder P
    Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.
    Schroeder JA; Thompson MC; Gardner MM; Gendler SJ
    J Biol Chem; 2001 Apr; 276(16):13057-64. PubMed ID: 11278868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.
    Al Masri A; Gendler SJ
    Oncogene; 2005 Sep; 24(38):5799-808. PubMed ID: 15897873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate P-cadherin expression in the mouse mammary epithelium is compatible with normal mammary gland function.
    Radice GL; Sauer CL; Kostetskii I; Peralta Soler A; Knudsen KA
    Differentiation; 2003 Aug; 71(6):361-73. PubMed ID: 12919105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
    de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
    Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Muc1 in MMTV-c-Neu tumors.
    Adriance MC; Gendler SJ
    Oncogene; 2004 Jan; 23(3):697-705. PubMed ID: 14737104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
    Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
    Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 triggers lineage plasticity of Her2 positive mammary tumors.
    Pang Z; Dong X; Deng H; Wang C; Liao X; Liao C; Liao Y; Tian W; Cheng J; Chen G; Yi H; Huang L
    Oncogene; 2022 May; 41(22):3064-3078. PubMed ID: 35461328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
    Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
    Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells.
    Chen D; Xia J; Tanaka Y; Chen H; Koido S; Wernet O; Mukherjee P; Gendler SJ; Kufe D; Gong J
    Immunology; 2003 Jun; 109(2):300-7. PubMed ID: 12757626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytoplasmic domain of MUC1 induces hyperplasia in the mammary gland and correlates with nuclear accumulation of β-catenin.
    Li Y; Yi H; Yao Y; Liao X; Xie Y; Yang J; Yan Z; Wang L; Lu S; Kuang Y; Gu M; Fei J; Wang Z; Huang L
    PLoS One; 2011 Apr; 6(4):e19102. PubMed ID: 21533058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor alpha dependent cancer progression is modulated by Muc1.
    Pochampalli MR; Bitler BG; Schroeder JA
    Cancer Res; 2007 Jul; 67(14):6591-8. PubMed ID: 17638868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of B7.1 in a MUC1-expressing mouse mammary epithelial tumour cell line inhibits tumorigenicity but does not induce autoimmunity in MUC1 transgenic mice.
    Smith M; Burchell JM; Graham R; Cohen EP; Taylor-Papadimitriou J
    Immunology; 1999 Aug; 97(4):648-55. PubMed ID: 10457219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice.
    Pittius CW; Hennighausen L; Lee E; Westphal H; Nicols E; Vitale J; Gordon K
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):5874-8. PubMed ID: 2842753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2.
    Grosso JF; Herbert LM; Owen JL; Lopez DM
    J Immunol; 2004 Aug; 173(3):1721-30. PubMed ID: 15265901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.